Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Carcinoma, Neuroendocrine 12Adrenocortical Carcinoma 9Neuroendocrine Tumors 5Small Cell Lung Carcinoma 4Thyroid Carcinoma, Anaplastic 3Peritoneal Neoplasms 3Gastrointestinal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Somatostatinoma 2Sarcoma 2Neoplasms 2Head and Neck Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Small Cell 2Wilms Tumor 1Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomach Neoplasms 1Rhabdomyosarcoma 1Retroperitoneal Neoplasms 1Pheochromocytoma 1Ovarian Neoplasms 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroendocrine Neoplasms 1Neuroblastoma 1Mesothelioma, Malignant 1Medulloblastoma 1Lung Neoplasms 1Liver Neoplasms 1

Interventions

fluorodopa F 18 4Octreotide 4Everolimus 4Capecitabine 4Temozolomide 3Leucovorin 3vatalanib 2Trastuzumab 2Oxaliplatin 2Fluorouracil 2Bortezomib 2Bevacizumab 268Ga-NOTA-exendin-4 2veliparib 1tipifarnib 1romidepsin 1regorafenib 1pentetreotide 1pazopanib 1pasireotide 1motesanib diphosphate 1cixutumumab 1batifiban 1Thalidomide 1Surgical Procedures, Operative 1Streptozocin 1Sorafenib 1Solutions 1Salts 1Saline Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Insulinoma × Cisplatin × Endocrine × Clear all
NCT00602082 2013-08-07

Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

National Cancer Institute (NCI)

Phase 2 Completed
84 enrolled
Endocrine

Glucagonoma, Insulinoma, Adenoma, Islet Cell, Somatostatinoma, Gastrinoma, Carcinoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡